McCamish Mark Anthony is a director of Rafael Holdings Inc - Ordinary Shares.
Person profile
Latest filings (excl ownership)
No filings
Latest ownership filings
4
Rafael Holdings, Inc.
8 Jan 24
4
AVADEL PHARMACEUTICALS PLC
29 Dec 23
144
AVADEL PHARMACEUTICALS PLC
28 Dec 23
4
AVADEL PHARMACEUTICALS PLC
15 Aug 23
144
AVADEL PHARMACEUTICALS PLC
11 Aug 23
4
AVADEL PHARMACEUTICALS PLC
3 Aug 23
4
Rafael Holdings, Inc.
5 Jan 23
4
AVADEL PHARMACEUTICALS PLC
5 Aug 22
4
Rafael Holdings, Inc.
5 Jan 22
4
AVADEL PHARMACEUTICALS PLC
5 Aug 21
Recent insider trades
Date | Company | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
5 Jan 24 | RFL Rafael Holdings Inc - Ordinary Shares | Class B Common Stock, par value $.01 per share | Grant | Acquire A | No | No | 1.81 | 27,655 | 50.06 k | 60,241 |
28 Dec 23 | AVDL Avadel Pharmaceuticals | ADSs | Sell | Dispose S | Yes | Yes | 14.53 | 75,000 | 1.09 mm | 67,025 |
11 Aug 23 | AVDL Avadel Pharmaceuticals | ADSs | Sell | Dispose S | Yes | No | 14.9306 | 28,975 | 432.61 k | 142,025 |
1 Aug 23 | AVDL Avadel Pharmaceuticals | Stock Option ADSs | Grant | Acquire A | No | No | 14.1 | 33,000 | 465.30 k | 33,000 |
5 Jan 23 | RFL Rafael Holdings Inc - Ordinary Shares | Class B Common Stock, par value $.01 per share | Grant | Acquire A | No | No | 1.84 | 27,174 | 50.00 k | 32,586 |